Viewing Study NCT07223593


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-26 @ 2:07 AM
Study NCT ID: NCT07223593
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-10-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module